Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging.

Jan Näslund, Angelika Schierhorn, Ulf Hellman, Lars Lannfelt, A.D. Roses, Lars O. Tjernberg, Jerzy Silberring, Sam Gandy, Bengt Winblad, Paul Greengard

Proceedings of the National Academy of Sciences · 1994 · 469 citations · 25 references

Concepts

Abstract

The Alzheimer A beta amyloid peptide (A beta) is the principal proteinaceous component of amyloid associated with Alzheimer disease (AD). We have determined the relative abundance of A beta structural variants present in amyloid from brains of 10 individuals with sporadic AD, 2 individuals with familial AD carrying specific mutations in the Alzheimer amyloid precursor protein gene, and 5 nondemented elderly controls. A procedure of isolation based on the extreme insolubility of A beta amyloid was used. The purified, nondigested A beta was analyzed by N-terminal sequencing and electrospray-ionization mass spectrometry. Three principal A beta variants were detected--A beta-(1-40), A beta-(1-42), and A beta-(11-42)--in all brains analyzed. The predominant variant in sporadic AD was A beta-(1-40), whereas the principal A beta variant in nondemented elderly controls was A beta-(1-42). The ratio A beta-(1-40)/A beta-(1-42) differed by 10-fold between brains from nondemented controls and those with sporadic AD.

References

25